生物
细菌
抗生素耐药性
微生物学
大肠杆菌
抗生素
分布(数学)
抗菌剂
芽孢杆菌(形态)
抗药性
生物技术
细菌遗传学
致病菌
全球卫生
大环内酯类抗生素
水平基因转移
最小抑制浓度
基因组
抗性(生态学)
人类健康
细菌蛋白
抵抗性
兽医学
作者
Yang Zhou,Yongqiang Yang,Yuqi Mao,Zhangqun Hou,Yiyang Xu,Kelei Zhao,Yiwen Chu,Xinrong Wang,Can Wang,Shun Li,Fei Xu,Likai Hao,Binbin Xie,JiaFu Lin,Tao Song
标识
DOI:10.1093/ismejo/wraf261
摘要
Abstract Macrolide antibiotics are vital for controlling infections in humans, animals, and agriculture, yet their effectiveness is increasingly compromised by antimicrobial resistance. Macrolide esterases (MLEs) are key mediators of macrolide resistance but have only been detected in Gram-negative bacteria, with no evidence in Gram-positive species. Here, we mined over 500,000 Gram-positive genomes and identified 8,707 candidate proteins. Six representative MLEs were functionally validated, conferring resistance to 16-membered macrolides and increasing minimum inhibitory concentrations up to 16-fold in Escherichia coli and 128-fold in Bacillus subtilis. Moreover, two exhibited broad-spectrum activity against all clinically and veterinary relevant 16-membered macrolides. Temporal analysis revealed that Gram-positive MLEs originated at least 2.7 million years ago, contrasting with their emergence in Gram-negative bacteria after the introduction of antibiotics. Genomic surveys further demonstrated the global distribution of MLE-carrying Gram-positive bacteria across 97 countries and diverse ecosystems, including clinical, food, agricultural, and natural environments. These findings highlight Gram-positive MLEs as an underrecognized risk and underscore the need for a One Health–oriented strategy to monitor, assess, and mitigate the spread of macrolide resistance across interconnected ecosystems.
科研通智能强力驱动
Strongly Powered by AbleSci AI